These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 18760278)

  • 21. PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1.
    Ghiotto M; Gauthier L; Serriari N; Pastor S; Truneh A; Nunès JA; Olive D
    Int Immunol; 2010 Aug; 22(8):651-60. PubMed ID: 20587542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue expression of PD-L1 mediates peripheral T cell tolerance.
    Keir ME; Liang SC; Guleria I; Latchman YE; Qipo A; Albacker LA; Koulmanda M; Freeman GJ; Sayegh MH; Sharpe AH
    J Exp Med; 2006 Apr; 203(4):883-95. PubMed ID: 16606670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis.
    Jurado JO; Alvarez IB; Pasquinelli V; Martínez GJ; Quiroga MF; Abbate E; Musella RM; Chuluyan HE; García VE
    J Immunol; 2008 Jul; 181(1):116-25. PubMed ID: 18566376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation.
    Kuipers H; Muskens F; Willart M; Hijdra D; van Assema FB; Coyle AJ; Hoogsteden HC; Lambrecht BN
    Eur J Immunol; 2006 Sep; 36(9):2472-82. PubMed ID: 16917960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production.
    Yamazaki T; Akiba H; Koyanagi A; Azuma M; Yagita H; Okumura K
    J Immunol; 2005 Aug; 175(3):1586-92. PubMed ID: 16034097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.
    Raziorrouh B; Ulsenheimer A; Schraut W; Heeg M; Kurktschiev P; Zachoval R; Jung MC; Thimme R; Neumann-Haefelin C; Horster S; Wächtler M; Spannagl M; Haas J; Diepolder HM; Grüner NH
    Gastroenterology; 2011 Oct; 141(4):1422-31, 1431.e1-6. PubMed ID: 21763239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD4 T-cell suppression by cells from Toxoplasma gondii-infected retinas is mediated by surface protein PD-L1.
    Charles E; Joshi S; Ash JD; Fox BA; Farris AD; Bzik DJ; Lang ML; Blader IJ
    Infect Immun; 2010 Aug; 78(8):3484-92. PubMed ID: 20498261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expression of PD-L1 and PD-L2 in dermal fibroblasts from alopecia areata mice.
    Li Y; Kilani RT; Pakyari M; Leung G; Nabai L; Ghahary A
    J Cell Physiol; 2018 Mar; 233(3):2590-2601. PubMed ID: 28777458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesenteric lymph node CD11b
    Shiokawa A; Kotaki R; Takano T; Nakajima-Adachi H; Hachimura S
    Immunology; 2017 Sep; 152(1):52-64. PubMed ID: 28423181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloproteinases cleave membrane-bound PD-L1 on CD90+ (myo-)fibroblasts in Crohn's disease and regulate Th1/Th17 cell responses.
    Aguirre JE; Beswick EJ; Grim C; Uribe G; Tafoya M; Chacon Palma G; Samedi V; McKee R; Villeger R; Fofanov Y; Cong Y; Yochum G; Koltun W; Powell D; Pinchuk IV
    Int Immunol; 2020 Jan; 32(1):57-68. PubMed ID: 31633754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No evidence for dualism in function and receptors: PD-L2/B7-DC is an inhibitory regulator of human T cell activation.
    Pfistershammer K; Klauser C; Pickl WF; Stöckl J; Leitner J; Zlabinger G; Majdic O; Steinberger P
    Eur J Immunol; 2006 May; 36(5):1104-13. PubMed ID: 16598819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colonic epithelial cell mediated suppression of CD4 T cell activation.
    Cruickshank SM; McVay LD; Baumgart DC; Felsburg PJ; Carding SR
    Gut; 2004 May; 53(5):678-84. PubMed ID: 15082586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human iris pigment epithelial cells suppress T-cell activation via direct cell contact.
    Hattori T; Kezuka T; Usui Y; Okunuki Y; Takeuchi M; Maruyama K; Haneda M; Shirato S; Goto H
    Exp Eye Res; 2009 Sep; 89(3):358-64. PubMed ID: 19379738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Forced expression of programmed death-1 gene on T cell decreased the incidence of type 1 diabetes.
    Won TJ; Jung YJ; Kwon SJ; Lee YJ; Lee DI; Min H; Park ES; Joo SS; Hwang KW
    Arch Pharm Res; 2010 Nov; 33(11):1825-33. PubMed ID: 21116786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PD-L1: PD-1 interaction contributes to the functional suppression of T-cell responses to human uveal melanoma cells in vitro.
    Yang W; Chen PW; Li H; Alizadeh H; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2518-25. PubMed ID: 18296654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PD-L2:PD-1 involvement in T cell proliferation, cytokine production, and integrin-mediated adhesion.
    Saunders PA; Hendrycks VR; Lidinsky WA; Woods ML
    Eur J Immunol; 2005 Dec; 35(12):3561-9. PubMed ID: 16278812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo.
    Sandner SE; Clarkson MR; Salama AD; Sanchez-Fueyo A; Domenig C; Habicht A; Najafian N; Yagita H; Azuma M; Turka LA; Sayegh MH
    J Immunol; 2005 Mar; 174(6):3408-15. PubMed ID: 15749874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intestinal myofibroblasts and immune tolerance.
    Saada JI; Barrera CA; Reyes VE; Adegboyega PA; Suarez G; Tamerisa RA; Pang KF; Bland DA; Mifflin RC; DI Mari JF; Powell DW
    Ann N Y Acad Sci; 2004 Dec; 1029():379-81. PubMed ID: 15681786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Programmed Cell Death Ligand (PD-L)-1 Contributes to the Regulation of CD4
    de Freitas E Silva R; Gálvez RI; Pereira VRA; de Brito MEF; Choy SL; Lotter H; Bosurgi L; Jacobs T
    Front Immunol; 2020; 11():574491. PubMed ID: 33193363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquisition of anergic and suppressive activities in transforming growth factor-beta-costimulated CD4+CD25- T cells.
    Park HB; Paik DJ; Jang E; Hong S; Youn J
    Int Immunol; 2004 Aug; 16(8):1203-13. PubMed ID: 15237111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.